Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Taminadenant |
| Trade Name | |
| Synonyms | NIR178|PBF-509 |
| Drug Descriptions |
Taminadenant binds to and inhibits the adenosine A2A (ADORA2A) receptor on immune cells, resulting in activation of an anti-tumor immune response by blocking binding of the immunosuppressive metabolite, adenosine (PMID: 29758241, PMID: 28582704). |
| DrugClasses | Adenosine Targeting 24 |
| CAS Registry Number | 1337962-47-6 |
| NCIT ID | C121664 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| DFF332 + Spartalizumab + Taminadenant | DFF332 Spartalizumab Taminadenant | 0 | 1 |
| Ieramilimab + Spartalizumab + Taminadenant | Ieramilimab Spartalizumab Taminadenant | 0 | 1 |
| KAZ954 + Taminadenant | KAZ954 Taminadenant | 0 | 1 |
| NZV930 + Spartalizumab + Taminadenant | NZV930 Spartalizumab Taminadenant | 0 | 1 |
| NZV930 + Taminadenant | NZV930 Taminadenant | 0 | 1 |
| Spartalizumab + Taminadenant | Spartalizumab Taminadenant | 0 | 2 |
| Taminadenant | Taminadenant | 0 | 1 |